BioKier's Seed - III Round

BioKier raised a round of funding on June 07, 2013.

BioKier is an early-stage pharmaceutical company developing drugs for diabetes and related disorders. BioKier has identified a therapeutic opportunity and is developing a treatment for type 2 diabetes…

Articles about BioKier's Seed - III Round: